| Literature DB >> 30244836 |
Jill J Bouchard1, Joel H Otero1, Daniel C Scott1, Elzbieta Szulc2, Erik W Martin1, Nafiseh Sabri1, Daniele Granata3, Melissa R Marzahn1, Kresten Lindorff-Larsen3, Xavier Salvatella4, Brenda A Schulman5, Tanja Mittag6.
Abstract
Mutations in the tumor suppressor SPOP (speckle-type POZ protein) cause prostate, breast, and other solid tumors. SPOP is a substrate adaptor of the cullin3-RING ubiquitin ligase and localizes to nuclear speckles. Although cancer-associated mutations in SPOP interfere with substrate recruitment to the ligase, mechanisms underlying assembly of SPOP with its substrates in liquid nuclear bodies and effects of SPOP mutations on assembly are poorly understood. Here, we show that substrates trigger phase separation of SPOP in vitro and co-localization in membraneless organelles in cells. Enzymatic activity correlates with cellular co-localization and in vitro mesoscale assembly formation. Disease-associated SPOP mutations that lead to the accumulation of proto-oncogenic proteins interfere with phase separation and co-localization in membraneless organelles, suggesting that substrate-directed phase separation of this E3 ligase underlies the regulation of ubiquitin-dependent proteostasis.Entities:
Keywords: Cul3; DAXX; NMR; androgen receptor; biomolecular codensates; multivalency; nuclear bodies; polymerization; prostate cancer; ubiquitination
Mesh:
Substances:
Year: 2018 PMID: 30244836 PMCID: PMC6179159 DOI: 10.1016/j.molcel.2018.08.027
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 19.328